From Sizable Stake Zero: Why Agios Backer Vanished
When a big investor exits a biotech stock, it rattles the market and raises questions. This deep dive explains the 'f...
Overview of a yearly tax planning approach for index fund losses, detailing steps to track opportunities, document losses, and optimize filings.
19,656 articlesWhen a big investor exits a biotech stock, it rattles the market and raises questions. This deep dive explains the 'f...
Canopy Growth just made a bold move aimed at turning around years of underperformance. This article breaks down the d...
Macerich faces a retail landscape that’s evolved in 2025. This deep dive breaks down the factors shaping macerich (ma...
Energy income investors face a critical test as crude prices swing. This report examines the dividend safety check: e...
Public backlash can move beyond headlines and into wallets. This in-depth look examines the financial ripple effects ...
Explore how Jean Eric Salata leads EQT Group to build durable value across private equity and beyond. This article di...
As investors eye the next earnings cycle, Sweetgreen's 2025 earnings outlook becomes a focal point for growth, margin...
A couple questions how to allocate a house-down payment fund during a layoff. The Ramsey Show host cautions that dipp...
Financial recovery goes hand in hand with personal recovery. This guide shows how to budget for treatment, tackle deb...
A presidential weekend met pop culture as the White House leaned into Taylor branding. Learn what this crossover mean...
EOSE stock has surged in a volatile stretch as investors weigh grid-scale storage growth against project risks. This ...
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...